Streetbeat News

Earnings

RUM

Rumble (NASDAQ:RUM) is scheduled to release its quarterly earnings report on March 27, 2024, with an estimated EPS of $-0.22. Analysts and investors are keen on whether Rumble will surpass this estimate and provide positive guidance for the next quarter. Historical data shows Rumble's stock price reacts to both earnings outcomes and forward-looking statements. Last quarter, Rumble exceeded EPS estimates, resulting in a 5.33% stock price increase. However, over the last year, Rumble's shares have declined by 17.2%, indicating a bearish outlook among long-term investors.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 2:00 pm

CCL

Carnival Corporation (NYSE:CCL) is scheduled to release its quarterly earnings report on March 27, 2024, with analysts expecting an EPS of $-0.18. Investors are hopeful for a beat on this estimate and positive guidance for the next quarter. Historical data shows mixed reactions in stock price to past earnings performances, with the last quarter's beat leading to a 1.35% drop in share price. Over the last year, CCL shares have increased by 74.79%, indicating a generally positive outlook among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 2:00 pm

GM

GM's CFO announced at the BofA Conference that demand remains strong, but anticipates an equity loss in China for Q1. This reflects the company's current financial outlook and market challenges in China.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 1:59 pm

GME

GameStop Corp (NYSE:GME) is in focus as it prepares to report its Q4 financial results after market close on Tuesday. Expected earnings are 29 cents per share on $2.05 billion in revenue. Last quarter, GME reported an earnings loss and missed revenue estimates but ended with $1.21 billion in cash and securities. A new investment policy allows CEO Ryan Cohen to manage the company's security investments. No conference call details were provided, continuing a trend from the past three quarters. GME shares surged over 15% on Monday.

Portfolio Pulse from Adam Eckert

March 26, 2024 | 1:44 pm

GANX

Gain Therapeutics (NASDAQ:GANX) reported Q4 earnings with losses of $(0.29) per share, surpassing the analyst consensus estimate of $(0.32) by 9.38%. This represents a 25.64% improvement over the previous year's losses of $(0.39) per share.

Portfolio Pulse from Happy Mohamed

March 26, 2024 | 1:30 pm

FRZA

Forza X1 (NASDAQ:FRZA) reported a Q4 EPS loss of $(0.08), an improvement from a $(0.15) loss per share YoY. Sales for the quarter were $18.56K.

Portfolio Pulse from Happy Mohamed

March 26, 2024 | 1:29 pm

CISS

C3is shares are trading higher following the announcement of improved Q4 financial results compared to the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 1:29 pm

GDS

GDS Holdings reported Q4 adjusted EPS of $(0.01), surpassing the $(0.33) estimate, and sales of $360.07M, exceeding the $357.63M estimate. This represents a significant improvement over the previous year's performance.

Portfolio Pulse from Happy Mohamed

March 26, 2024 | 1:29 pm

BLRX

BioLine Rx (NASDAQ:BLRX) reported Q4 earnings with losses of $(0.15) per share, surpassing the $(0.22) estimate, marking a 31.82% beat. However, this represents an 87.5% increase in losses from the previous year. Sales reached $4.80 million for the quarter.

Portfolio Pulse from Happy Mohamed

March 26, 2024 | 1:28 pm

CGTX

Cognition Therapeutics (NASDAQ:CGTX) reported Q4 losses of $(0.27) per share, surpassing the analyst consensus estimate of $(0.34) by 20.59%. However, this represents a 35% increase in losses compared to $(0.20) per share from the same period last year.

Portfolio Pulse from Happy Mohamed

March 26, 2024 | 1:28 pm